Trump’s Renewed Focus on Pharmacy Benefit Managers Sends Healthcare Stocks Tumbling
Trump’s renewed focus on Pharmacy Benefit Managers (PBMs) sends healthcare stocks tumbling, signaling potential reforms. Congressional scrutiny adds to the pressure, raising questions about PBMs’ future and impact on drug pricing.
Trump’s Renewed Focus on Pharmacy Benefit Managers Sends Healthcare Stocks Tumbling Read More »